| Literature DB >> 8637302 |
Abstract
The major findings of the LHS that have been reported thus far are that an effective smoking cessation program can be developed that can produce more than a 20% success rate in getting smokers to give up the habit permanently, and that by stopping smoking, individuals with early COPD benefit by having an initial improvement in lung function and a slowing of the annual loss of their FEV1. The use of a bronchodilator has a short-term effect in improving the FEV1, but it does not affect long-term changes in lung function. AHR is common in patients with mild-to-moderate COPD. The reward for a smoker to give up the habit is an initial gain in FEV1 and a subsequent close to normal annual rate of decline of this pulmonary function parameter. These results should provide a positive incentive for smokers to quit and thereby decrease the morbidity and mortality caused by the use of tobacco.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8637302 DOI: 10.1016/s0025-7125(05)70452-1
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456